Sandoz: Jayeeta Chatterjee appointed as Head - HCM Transformation Ruchika Sharma29 May 2025 5:40 PM ISTJayeeta Chatterjee has joined Sandoz as Head - HCM Transformation (P&O).In a recent LinkedIn post, Chatterjee said, "I'm delighted to...
Arthritis drug: Sandoz files US antitrust litigation against Amgen Ruchika Sharma14 April 2025 2:30 PM ISTSandoz is seeking an injunction to prevent Amgen from using certain patent rights to block biosimilar competition and allow Sandoz to launch Erelzi.
Avecho, Sandoz ink pact to commercialise CBD for insomnia in Australia Ruchika Sharma6 March 2025 11:30 AM ISTMelbourne: Avecho Biotechnology Limited has announced it has signed an exclusive ten-year development and licensing agreement with Sandoz Group...
Sandoz family foundation offers USD 3 billion worth of Novartis shares Ruchika Sharma27 Feb 2025 5:04 PM ISTEmasan AG, a subsidiary of the Sandoz Family Foundation, has initiated a public offering of approximately 26.5 million shares in Novartis, aiming to...
Drug price fixation: Sandoz to pay $275 million to settle case Ruchika Sharma20 Feb 2025 4:24 PM ISTSandoz has agreed to pay $275 million to settle claims that it conspired with competitors to fix prices illegally.Attorneys representing the...
USFDA approves Caplin Steriles eye drop Ruchika Sharma16 Dec 2024 2:30 PM ISTChennai: Caplin Steriles Limited, a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval by the...
Sandoz gets USFDA nod for Enzeevu Ruchika Sharma12 Aug 2024 4:04 PM ISTBasel: Sandoz has announced that the US Food and Drug Administration (FDA) has approved Enzeevu (aflibercept-abzv) 2 mg vial kit and pre-filled...
Alembic Pharma bags USFDA final nod for cancer injection Nelarabine Ruchika Sharma2 Aug 2024 12:30 PM ISTVadodara: Alembic Pharmaceuticals Limited today announced that the Company has received final approval from the US Food & Drug...
Sandoz unveils biosimilar Pyzchiva across Europe to treat chronic inflammatory diseases Ruchika Sharma28 July 2024 10:30 AM ISTBasel: Sandoz has announced the launch of Pyzchiva (ustekinumab) across Europe. Pyzchiva, developed and registered by Samsung Bioepis, a ustekinumab...
Lupin bags USFDA nod for Travoprost Ophthalmic Solution Ruchika Sharma7 May 2024 11:43 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
Sandoz confirms European Commission nod of Pyzchiva Ruchika Sharma23 April 2024 11:54 AM ISTBasel: Sandoz has announced that the European Commission (EC) has granted marketing authorization for Pyzchiva (biosimilar ustekinumab) developed...
Sandoz concludes acquisition of Cimerli business from Coherus BioSciences Ruchika Sharma5 March 2024 10:30 AM ISTCIMERLI is indicated for the treatment of certain retinal diseases that, if left untreated, can cause vision loss, which ranks among the top 10 causes...
